ACTIVATION OF THE A10 MESOLIMBIC SYSTEM BY THE SIGMA-RECEPTOR AGONIST (+)SKF 10,047 CAN BE BLOCKED BY RIMCAZOLE, A NOVEL PUTATIVE ANTIPSYCHOTIC

被引:94
作者
CECI, A
SMITH, M
FRENCH, ED
机构
[1] UNIV ARIZONA,COLL MED,DEPT PHARMACOL,TUCSON,AZ 85724
[2] MARYLAND PSYCHIAT RES CTR,NEUROSCI PROGRAM,BALTIMORE,MD 21228
关键词
D O I
10.1016/0014-2999(88)90362-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:53 / 57
页数:5
相关论文
共 17 条
[1]   AN EARLY PHASE-II CLINICAL-TRIAL OF BW234U IN THE TREATMENT OF ACUTE SCHIZOPHRENIA IN NEWLY ADMITTED PATIENTS [J].
CHOUINARD, G ;
ANNABLE, L .
PSYCHOPHARMACOLOGY, 1984, 84 (02) :282-284
[2]   AN ENDOGENOUS LIGAND FOR THE SIGMA-OPIOID BINDING-SITE [J].
CONTRERAS, PC ;
DIMAGGIO, DA ;
ODONOHUE, TL .
SYNAPSE, 1987, 1 (01) :57-61
[3]  
DAVIDSON J, 1982, Psychopharmacology Bulletin, V18, P173
[4]   RIMCAZOLE (BW U-234), A NOVEL ANTIPSYCHOTIC AGENT WHOSE MECHANISM OF ACTION CANNOT BE EXPLAINED BY A DIRECT BLOCKADE OF POSTSYNAPTIC DOPAMINERGIC RECEPTORS IN BRAIN [J].
FERRIS, RM ;
WHITE, HL ;
TANG, FLM ;
RUSSELL, A ;
HARFENIST, M .
DRUG DEVELOPMENT RESEARCH, 1986, 9 (03) :171-188
[5]   BW234U, (CIS-9-[3-(3,5-DIMETHYL-1-PIPERAZINYL)PROPYL]CARBAZOLE DIHYDROCHLORIDE) - A NOVEL ANTIPSYCHOTIC AGENT [J].
FERRIS, RM ;
HARFENIST, M ;
MCKENZIE, GM ;
COOPER, B ;
SOROKO, FE ;
MAXWELL, RA .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1982, 34 (06) :388-390
[6]   EVIDENCE THAT THE POTENTIAL ANTIPSYCHOTIC AGENT RIMCAZOLE (BW U-234) IS A SPECIFIC, COMPETITIVE ANTAGONIST OF SIGMA-SITES IN BRAIN [J].
FERRIS, RM ;
TANG, FLM ;
CHANG, KJ ;
RUSSELL, A .
LIFE SCIENCES, 1986, 38 (25) :2329-2337
[7]   THE EFFECTS OF PHENCYCLIDINE AND N-ALLYLNORMETAZOCINE ON MIDBRAIN DOPAMINE NEURONAL-ACTIVITY [J].
FREEMAN, AS ;
BUNNEY, BS .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 104 (3-4) :287-293
[8]   EFFECTS OF PHENCYCLIDINE ON VENTRAL TEGMENTAL A-10 DOPAMINE NEURONS IN THE RAT [J].
FRENCH, ED .
NEUROPHARMACOLOGY, 1986, 25 (03) :241-248
[10]   PSYCHOTROPIC ACTIONS OF BW-234U IN THE TREATMENT OF INPATIENT SCHIZOPHRENICS - A DOSE-RANGE STUDY [J].
GUY, W ;
MANOV, G ;
WILSON, WH ;
BAN, TA ;
FJETLAND, OK ;
MANBERG, PJ ;
DREN, AT .
DRUG DEVELOPMENT RESEARCH, 1983, 3 (03) :245-252